Biomarin Pharmaceutical Inc BMRN:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/17/21 EDT
77.76quote price arrow up+1.26 (+1.65%)
Volume
2,345,248
52 week range
71.65 - 92.56
Loading...
  • Open76.42
  • Day High77.98
  • Day Low76.40
  • Prev Close77.76
  • 52 Week High92.56
  • 52 Week High Date12/17/20
  • 52 Week Low71.65
  • 52 Week Low Date11/03/20

Key Stats

  • Market Cap14.257B
  • Shares Out183.35M
  • 10 Day Average Volume1.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.54
  • YTD % Change-11.32

KEY STATS

  • Open76.42
  • Day High77.98
  • Day Low76.40
  • Prev Close77.76
  • 52 Week High92.56
  • 52 Week High Date12/17/20
  • 52 Week Low71.65
  • 52 Week Low Date11/03/20
  • Market Cap14.257B
  • Shares Out183.35M
  • 10 Day Average Volume1.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.54
  • YTD % Change-11.32

RATIOS/PROFITABILITY

  • EPS (TTM)-0.13
  • P/E (TTM)-578.57
  • Fwd P/E (NTM)-137.39
  • EBITDA (MRQ)60.39M
  • ROE (MRQ)-0.67%
  • Revenue (MRQ)1.917B
  • Gross Margin (MRQ)70.67%
  • Net Margin (MRQ)-1.32%
  • Debt To Equity (MRQ)25.39%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomarin Pharmaceutical Inc

Profile

MORE
BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS)...
Jean-Jacques Bienaime
Chairman
Brian Mueller CPA
Chief Financial Officer
Andrea Acosta
Chief Accounting Officer
C. Greg Guyer Ph.D.
Executive Vice President
Jeff Ajer
Executive Vice President
Address
105 Digital Dr
Novato, CA
94949-8703
United States

Top Peers

SYMBOLLASTCHG%CHG
RDY
Dr Reddy's Laboratories Ltd
66.35-0.57-0.85%
UTHR
United Therapeutics Corp
200.08-5.06-2.47%
ELAN
Elanco Animal Health Inc
32.40-0.07-0.22%
RPRX
Royalty Pharma PLC
38.50+0.12+0.31%
BPMC
Blueprint Medicines Corp
106.00+3.04+2.95%